BREAKING: FDA Would Allow Biosimilar Labels to Rely on Reference Drug Data

In a new article via Modern Healthcare, “Biologic manufacturers may not be pleased with the long-awaited biosimilar labeling guidelines released by the Food and Drug Administration on Thursday.”  For more information, please visit: http://www.modernhealthcare.com/article/20160331/NEWS/160339988?utm_source=modernhealthcare&utm_medium=email&utm_content=20160331-NEWS-160339988&utm_campaign=mh-alert